Kevin C. Knightly files SEC Form 4 disclosures for IQVIA HOLDINGS INC.. They have made 18 open-market trades across 4 companies since 2007, most recently 2024-02-28.
CIK 0001350000
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IQV | SELL | 2024-02-28 | 2024-03-01 | $250.17 | $4.3M | +1.8% | -0.9% | -11.4% |
| IQV | SELL | 2024-02-16 | 2024-02-21 | $241.10 | $6.5M | +5.5% | +5.8% | -3.8% |
| IQV | SELL | 2023-12-01 | 2023-12-05 | $214.03 | $5.6M | +4.9% | +1.9% | +16.4% |
| IQV | SELL | 2023-06-05 | 2023-06-07 | $201.89 | $2.3M | +3.2% | +4.1% | +6.1% |
| IQV | SELL | 2023-05-26 | 2023-05-31 | $198.66 | $199 | +7.3% | +13.9% | +14.1% |
| IQV | SELL | 2023-02-16 | 2023-02-17 | $225.61 | $2.0M | -0.4% | -11.5% | -9.8% |
| IQV | SELL | 2021-08-16 | 2021-08-18 | $250.00 | $1.5M | +3.3% | +1.2% | +5.7% |
| IQV | SELL | 2020-02-21 | 2020-02-25 | $163.43 | $716K | -10.1% | -27.0% | -5.2% |
| IQV | SELL | 2020-02-19 | 2020-02-20 | $165.09 | $1.9M | -13.5% | -48.6% | -11.0% |
| IQV | SELL | 2019-08-01 | 2019-08-05 | $158.50 | $678K | -0.3% | -0.8% | -4.0% |
| IQV | SELL | 2019-07-29 | 2019-07-31 | $158.53 | $2.2M | -3.2% | -2.9% | -6.0% |
| IQV | SELL | 2019-05-03 | 2019-05-07 | $138.06 | $12.7M | -0.8% | +2.0% | +12.7% |
| IQV | SELL | 2018-09-07 | 2018-09-11 | $126.46 | $2.3M | +2.4% | -1.7% | -4.4% |
| Q | SELL | 2017-08-25 | 2017-08-28 | $99.52 | $2.2M | -6.2% | -1.0% | -1.0% |
| Q | SELL | 2017-08-09 | 2017-08-11 | $90.28 | $1.8M | -6.2% | -1.0% | -1.0% |
| IMS | SELL | 2015-11-23 | 2015-11-25 | $28.50 | $548K | N/A | N/A | N/A |
| IMS | SELL | 2015-11-18 | 2015-11-20 | $28.37 | $1.6M | N/A | N/A | N/A |
| RX | SELL | 2007-02-20 | 2007-02-22 | $29.61 | $4.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.